Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets


USD 2,450.00

* Required Fields

USD 2,450.00


Be the first to review this product

The research service provides an analysis of Cox-2 inhibitors in three possible scenarios. A pessimistic, conservative, and optimistic scenario is manipulated by impacting factors. Included in each scenario are drug revenue forecasts, number of patients anticipated to shift from Vioxx, patient forecasts and analysis.

Table of Contents

Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor Markets, Vioxx Recall - Revenue Analysis and Impact on Cox-2 Inhibitor MarketsMarket Analysis Before RecallOverview and Research MethodologyIndicationsPricing Trends Patient ForecastsRevenue ForecastsMarket Analysis After RecallPatients ShiftingPessimistic ScenarioConservative ScenarioOptimistic ScenarioRecommendations and ConclusionDecision Support DatabasesArthritis PrevalencePopulation 55 and AboveCardiologistsStroke IncidenceOrthopaedists




Related Research

Release Date : 18-Apr-18

Region : North America

Release Date : 13-Apr-18

Region : North America

Release Date : 09-Apr-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.